Medications that activate both GLP-1 and GIP receptors produce even better results, with tirzepatide showing 22.5% average weight loss compared to semaglutides 14.9%
13 Since then, several other GLP-1RAs have undergone clinical trials and have been approved for this use in adults, and they have become increasingly readily available to the public over the last few years
Metabolic Medical Centers will work with you to develop an individualized plan based on your goals and lifestyle needs
Effective programs pair GLP-1 therapy with lifestyle change, medication optimization and de-escalation, coaching, side-effect management and care escalation
2) Pancreatitis Concerns Acute pancreatitis, including potentially fatal hemorrhagic and necrotizing types of pancreatitis, has been documented in those taking some GLP-1 RAs
"Wegovy pill, the first and only oral GLP-1 for weight loss in adults, now broadly available." Novo Nordisk GoodRx